Sherman, E. J., Michel, L. S., Kriplani, A., Wong, W., Haque, S., Yllanes, R., Knauf, J. A., Fagin, J. A., Ho, A. L. (2025). Pilot study evaluating the addition of cemiplimab in BRAF-mutant anaplastic thyroid cancer after progression on dabrafenib and trametinib.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e18149